
University of California, Berkeley, Boalt Hall School of Law (J.D., 1997), Associate Editor, California Law Review; Brigham Young University (B.S., magna cum laude, 1992).
California.
State Bar of California; Steering Committee, Life Sciences Venture Capital Network, BIOCOM San Diego.
Kirt Shuldberg joined the firm in 2003 and practices corporate and securities law. He is a member of the Life Sciences, Corporate/VLG, Clean Technology and Mergers and Acquisitions Practice Groups. In July 2008 Mr. Shuldberg relocated from San Diego to the firm’s office in London.
Mr. Shuldberg has a corporate and securities law practice with a focus on general corporate counseling, venture capital, private placements, mergers and acquisitions, public offerings, strategic collaborations and licensing transactions, and restructurings. He has represented clients in transactions ranging start-up financings to large public offerings and M&A transactions. He maintains a special focus on the life sciences, medical device and clean technology industries and has counseled companies in such other diverse industries as digital entertainment, software, Internet, telecommunications and wireless technologies. He has extensive experience advising private and public companies with respect to strategic capital-raising transactions and has advised on hundreds of financing transactions. Mr. Shuldberg represents several of California’s most prominent venture capital funds, as well as prominent venture capital funds from Europe and Asia, in their investments in life sciences, clean technology and technology companies. Venture capital funds Mr. Shuldberg has represented include Benchmark Capital, BB Biotech (Bellevue Asset Management), Enterprise Partners, Forward Ventures, JAFCO Life Sciences, Kleiner Perkins Caufield & Byers, Mission Ventures, Prism Ventureworks and Technology Partners. His life sciences, medical device and clean technology engagements include companies that operate in the following areas: biofuels, biopharmaceuticals, discovery informatics, drug discovery tools and services, energy storage, genetic research kits, injectable products for dermatology and plastic surgery, molecular diagnostics, personalized diagnostics, pharmaceuticals, proteomics, resorbable coronary stents, and stem cell research. Prior to entering law school, Mr. Shuldberg was a Senior Accountant at KPMG Peat Marwick.
University of California, Berkeley, Boalt Hall School of Law (J.D., 1997), Associate Editor, California Law Review; Brigham Young University (B.S., magna cum laude, 1992).
California.
State Bar of California; Steering Committee, Life Sciences Venture Capital Network, BIOCOM San Diego.
Mr. Shuldberg speaks regularly on topics of interest to emerging company executives and investors.